Ex Vivo Expanded Donor Alloreactive Regulatory T Cells Lose Immunoregulatory, Proliferation, and Antiapoptotic Markers After Infusion Into ATG-lymphodepleted, Nonhuman Primate Heart Allograft Recipients
暂无分享,去创建一个
A. Thomson | A. Zahorchak | Hong Zhang | M. Ezzelarab | H. Dai | J. Bhama | A. Perez-Gutierrez | K. Sasaki | D. J. van der Windt | Lien Lu
[1] James A. Hutchinson,et al. Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials , 2020, The Lancet.
[2] K. Okumura,et al. A Clinical Trial With Adoptive Transfer of Ex Vivo-induced, Donor-specific Immune-regulatory Cells in Kidney Transplantation—A Second Report , 2020, Transplantation.
[3] Trent M. Prall,et al. Characterization of 100 extended major histocompatibility complex haplotypes in Indonesian cynomolgus macaques , 2019, bioRxiv.
[4] R. Lechler,et al. Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation , 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] B. Hering,et al. Translational impact of NIH-funded nonhuman primate research in transplantation , 2019, Science Translational Medicine.
[6] Mihail I Mitov,et al. mTOR Inhibitor Everolimus in Regulatory T Cell Expansion for Clinical Application in Transplantation , 2019, Transplantation.
[7] M. Levings,et al. Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cells. , 2019, JCI insight.
[8] R. Lechler,et al. IL‐2 therapy preferentially expands adoptively transferred donor‐specific Tregs improving skin allograft survival , 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[9] M. Levings,et al. Taking regulatory T-cell therapy one step further , 2018, Current opinion in organ transplantation.
[10] I. Anegon,et al. Advances on CD8+ Treg Cells and Their Potential in Transplantation. , 2018, Transplantation.
[11] M. Ansari,et al. A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants , 2018, Scientific Reports.
[12] M. Levings,et al. Guiding regulatory T cells to the allograft , 2017, Current opinion in organ transplantation.
[13] M. Sarwal,et al. Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] M. Levings,et al. Harnessing Advances in T Regulatory Cell Biology for Cellular Therapy in Transplantation , 2017, Transplantation.
[15] Giovanna Lombardi,et al. Treg therapy in transplantation: a general overview , 2017, Transplant international : official journal of the European Society for Organ Transplantation.
[16] F. Vincenti,et al. Transplant trials with Tregs: perils and promises. , 2017, The Journal of clinical investigation.
[17] S. Todo,et al. A pilot study of operational tolerance with a regulatory T‐cell‐based cell therapy in living donor liver transplantation , 2016, Hepatology.
[18] R. Wiseman,et al. Regulatory T Cell Infusion Can Enhance Memory T Cell and Alloantibody Responses in Lymphodepleted Nonhuman Primate Heart Allograft Recipients , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[19] Jeffrey A. Bluestone,et al. Type 1 diabetes immunotherapy using polyclonal regulatory T cells , 2015, Science Translational Medicine.
[20] S. Brouard,et al. Regulatory T Cells in Kidney Transplantation: New Directions? , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[21] R. Wiseman,et al. Sequential Monitoring and Stability of Ex Vivo–Expanded Autologous and Nonautologous Regulatory T Cells Following Infusion in Nonhuman Primates , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[22] A. Thomson,et al. Generation, cryopreservation, function and in vivo persistence of ex vivo expanded cynomolgus monkey regulatory T cells. , 2015, Cellular immunology.
[23] M. Levings,et al. Control of tissue‐localized immune responses by human regulatory T cells , 2015, European journal of immunology.
[24] A. Kirk,et al. Superiority of Rapamycin Over Tacrolimus in Preserving Nonhuman Primate Treg Half‐Life and Phenotype After Adoptive Transfer , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[25] Q. Tang,et al. Attenuation of Donor‐Reactive T Cells Allows Effective Control of Allograft Rejection Using Regulatory T Cell Therapy , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[26] M. Atkinson,et al. Anti-thymocyte globulin (ATG) differentially depletes naïve and memory T cells and permits memory-type regulatory T cells in nonobese diabetic mice , 2012, BMC Immunology.
[27] K. Wood,et al. Regulatory immune cells in transplantation , 2012, Nature Reviews Immunology.
[28] W. Elyaman,et al. Ex Vivo Expansion of Human Tregs by Rabbit ATG Is Dependent on Intact STAT3‐Signaling in CD4+ T Cells and Requires the Presence of Monocytes , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[29] A. Nagler,et al. Anti-T Lymphocyte Globulin (ATG) Induces Generation of Regulatory T Cells, at Least Part of Them Express Activated CD44 , 2012, Journal of Clinical Immunology.
[30] S. Qi,et al. Adoptive transfer of CD4+CD25+ regulatory cells combined with low-dose sirolimus and anti-thymocyte globulin delays acute rejection of renal allografts in Cynomolgus monkeys. , 2011, International immunopharmacology.
[31] J. Wagner,et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. , 2011, Blood.
[32] A. Thomson,et al. Non-human primate regulatory T cells: current biology and implications for transplantation. , 2010, Transplantation.
[33] M. Kalos,et al. Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[34] R. Jessberger,et al. Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. , 2009, Immunity.
[35] P. Munson,et al. Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro. , 2007, Blood.
[36] L. Turka,et al. Allograft rejection mediated by memory T cells is resistant to regulation , 2007, Proceedings of the National Academy of Sciences.
[37] J. Bluestone,et al. CD4+CD25+ Regulatory T Cells in Transplantation: Progress, Challenges and Prospects , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[38] David D. Smith,et al. CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells. , 2006, Cancer research.
[39] M. Kimikawa,et al. Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates. , 2005, The Journal of clinical investigation.
[40] M. Roncarolo,et al. Human Cd25+Cd4+ T Regulatory Cells Suppress Naive and Memory T Cell Proliferation and Can Be Expanded in Vitro without Loss of Function , 2001, The Journal of experimental medicine.
[41] T. G. S. Wilson,et al. The Second Report , 1965 .